Orange Book product · Generic (ANDA)
PROPOXYPHENE COMPOUND 65
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
At a glance
Sep 16, 1983
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 16, 1983
43 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
Strength
389MG;32.4MG;65MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 080044
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
- 1983DARVON COMPOUNDBrand (NDA)
NDA 010996 · XANODYNE PHARM
- 1985PROPOXYPHENE COMPOUND-65Generic (ANDA)
ANDA 083101 · SANDOZ
- 1985PROPOXYPHENE COMPOUND 65Generic (ANDA)
ANDA 089025 · TEVA
- 1984PROPOXYPHENE COMPOUND 65Generic (ANDA)
ANDA 083077 · IVAX SUB TEVA PHARMS
- 1984PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINEGeneric (ANDA)
ANDA 085732 · WATSON LABS
- 1983COMPOUND 65Generic (ANDA)
ANDA 084553 · ALRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
